Form 4: Amgen Director Wanda M. Austin Reports Acquisition of 719 Shares of Common Stock

Director Wanda M. Austin reports acquiring 719 shares of Amgen Inc. common stock on May 31, 2024, through the vesting of restricted stock units.

Summary

• Wanda M. Austin, a director of Amgen Inc., filed a Form 4 on June 4, 2024, reporting a transaction that occurred on May 31, 2024.
• The transaction involved the acquisition of 719 shares of Amgen's common stock through the vesting of Restricted Stock Units (RSUs).
• The RSUs were granted under the Amgen Inc. 2009 Director Incentive Program and vested immediately.
• Following the reported transaction, Austin beneficially owns 6,544 shares of Amgen common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director acquiring shares through vested RSUs, which is neither particularly positive nor negative.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's acquisition of company stock, which is a common occurrence.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates